Buchumschlag

Indications and outcome of surgery for small nonfunctioning pancreatic neuroendocrine neoplasms (≤2 cm)

Objective - Optimal treatment strategies for small (≤2 cm) nonfunctioning pancreatic neuroendocrine neoplasms are still subject to discussion. The aim of this study was to analyze real-world data of patients with pancreatic neuroendocrine neoplasms ≤2 cm regarding the indications for surgery and lon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bechtiger, Fabiola A. (VerfasserIn) , Nießen, Anna (VerfasserIn) , Hinz, Ulf (VerfasserIn) , Lewosinska, Magdalena (VerfasserIn) , Hamm, Alexander (VerfasserIn) , Czigány, Zoltán (VerfasserIn) , Billmann, Franck (VerfasserIn) , Hackert, Thilo (VerfasserIn) , Büchler, Markus W. (VerfasserIn) , Schimmack, Simon (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 24 September 2025
In: Surgery
Year: 2025, Jahrgang: 188, Pages: 1-8
ISSN:1532-7361
DOI:10.1016/j.surg.2025.109730
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.surg.2025.109730
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0039606025005823
Volltext
Verfasserangaben:Fabiola A. Bechtiger, Anna Nießen, Ulf Hinz, Magdalena Lewosinska, Alexander Hamm, Zoltan Czigany, Franck Billmann, Thilo Hackert, Markus W. Büchler, Simon Schimmack
Beschreibung
Zusammenfassung:Objective - Optimal treatment strategies for small (≤2 cm) nonfunctioning pancreatic neuroendocrine neoplasms are still subject to discussion. The aim of this study was to analyze real-world data of patients with pancreatic neuroendocrine neoplasms ≤2 cm regarding the indications for surgery and long-term postresection survival. - Methods - All patients undergoing surgery for nonfunctioning pancreatic neuroendocrine neoplasms ≤2 cm between 2003 and 2023 were analyzed. Indications for surgery, clinicopathologic parameters, and long-term survival were assessed. Differences between pancreatic neuroendocrine neoplasms <1 cm and 1-2 cm were evaluated. - Results - Of a total of 806 resected pancreatic neuroendocrine neoplasms, 237 patients had a lesion ≤2 cm (29.4%), 85 of which were smaller than 1 cm. The 3 most common indications for surgery for pancreatic neuroendocrine neoplasms ≤2 cm were either suspicion of a non-neuroendocrine neoplasm malignancy (55.2%), suspicion of neuroendocrine tumor (25.9%), or obstruction of the pancreatic duct (9.4%). Tumor differentiation was 84% G1, 15% G2, and 1.3% G3. Noticeably, 5.1% of pancreatic neuroendocrine neoplasms ≤2 cm had lymph node metastasis (pN1). Five patients with a small pancreatic neuroendocrine neoplasm developed distant metastasis (pM1). The 10-year overall survival was 86.9% for <1 cm and 84.5% for 1-2 cm (P = .964). 10-year disease-free survival was 83.1% in patients with a pancreatic neuroendocrine neoplasms <1 cm and 81.1% for pancreatic neuroendocrine neoplasms 1-2 cm (P = .784). - Conclusion - Surgical treatment of small (≤2 cm) pancreatic neuroendocrine neoplasms provides excellent long-term survival. Since even small pancreatic neuroendocrine neoplasms can develop lymph node and distant metastases, treatment decisions should not be determined on the basis of tumor size alone.
Beschreibung:Gesehen am 28.01.2026
Beschreibung:Online Resource
ISSN:1532-7361
DOI:10.1016/j.surg.2025.109730

Ähnliche Einträge